Drugs / AS1501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06916585 | Jun 2026 → Nov 2027 expected | liver disorder | Shenzhen Third People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS1501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06916585 ↗ |
| Route | Intravenous | “single intravenous dose” NCT06916585 ↗ |